These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 19327043)

  • 1. Intraocular penetration of antimicrobial agents in ophthalmic infections and drug delivery strategies.
    Velpandian T
    Expert Opin Drug Deliv; 2009 Mar; 6(3):255-70. PubMed ID: 19327043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled transscleral drug delivery formulations to the eye: establishing new concepts and paradigms in ocular anti-inflammatory therapeutics and antibacterial prophylaxis.
    Paganelli F; Cardillo JA; Dare AR; Melo LA; Lucena DR; Silva AA; Oliveira AG; Pizzolitto AC; Lavinsky D; Skaf M; Souza-Filho AA; Höfling-Lima AL; Nguyen QD; Kuppermann BD; Herrero-Vanrell R; Belfort R;
    Expert Opin Drug Deliv; 2010 Aug; 7(8):955-65. PubMed ID: 20645672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraocular pharmacokinetics of intravenously administered marbofloxacin in rabbits with experimentally induced acute endophthalmitis.
    Regnier A; Schneider M; Concordet D; Toutain PL
    Am J Vet Res; 2008 Mar; 69(3):410-5. PubMed ID: 18312141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of ocular drug penetration.
    Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
    Crit Rev Ther Drug Carrier Syst; 1999; 16(1):85-146. PubMed ID: 10099899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers.
    Al-Kassas RS; El-Khatib MM
    Drug Deliv; 2009 Apr; 16(3):145-52. PubMed ID: 19514974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.
    Souto EB; Doktorovova S; Gonzalez-Mira E; Egea MA; Garcia ML
    Curr Eye Res; 2010 Jul; 35(7):537-52. PubMed ID: 20597640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial agents in infections of the central nervous system and eye.
    Papastamelos AG; Tunkel AR
    Infect Dis Clin North Am; 1995 Sep; 9(3):615-37. PubMed ID: 7490436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peri- and intra-ocular drug therapy in the treatment of endophthalmitis.
    Goldman HB
    Ophthalmic Semin; 1977; 2(2):167-201. PubMed ID: 327375
    [No Abstract]   [Full Text] [Related]  

  • 9. Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations.
    Loftsson T; Sigurdsson HH; Konrádsdóttir F; Gísladóttir S; Jansook P; Stefánsson E
    Pharmazie; 2008 Mar; 63(3):171-9. PubMed ID: 18444504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug delivery systems for the eye.
    Kearns VR; Williams RL
    Expert Rev Med Devices; 2009 May; 6(3):277-90. PubMed ID: 19419285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
    Jiao J
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1663-73. PubMed ID: 18845195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capacity and tolerance of a new device for ocular drug delivery.
    Pijls RT; Cruysberg LP; Nuijts RM; Dias AA; Koole LH
    Int J Pharm; 2007 Aug; 341(1-2):152-61. PubMed ID: 17524579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan nanoparticles for drug delivery to the eye.
    Paolicelli P; de la Fuente M; Sánchez A; Seijo B; Alonso MJ
    Expert Opin Drug Deliv; 2009 Mar; 6(3):239-53. PubMed ID: 19290841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Emphasizing the research for ocular drug delivery system].
    Chen ZJ
    Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):292-5. PubMed ID: 16762202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
    Myles ME; Neumann DM; Hill JM
    Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intracameral penetration of pefloxacine in man].
    Bron A; Talon D; Delbosc B; Estavoyer JM; Prost F; Montard M
    J Fr Ophtalmol; 1986; 9(4):317-21. PubMed ID: 3495563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnology in ocular drug delivery.
    Sahoo SK; Dilnawaz F; Krishnakumar S
    Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoral delivery of antimicrobials.
    Raj PA; Dentino AR
    Drug News Perspect; 2005; 18(6):362-74. PubMed ID: 16247514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iontophoresis: a non-invasive ocular drug delivery.
    Eljarrat-Binstock E; Domb AJ
    J Control Release; 2006 Feb; 110(3):479-89. PubMed ID: 16343678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical and systemic drug delivery to the posterior segments.
    Hughes PM; Olejnik O; Chang-Lin JE; Wilson CG
    Adv Drug Deliv Rev; 2005 Dec; 57(14):2010-32. PubMed ID: 16289435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.